Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 7, 2006 - Issue 14
Submit an article Journal homepage
56
Views
5
CrossRef citations to date
0
Altmetric
Review

Economic evaluation of the prevention and management of systemic fungal infections in neutropenic patients

Karen Moeremans Scientific Project Coordinator, HEDM-IMSHealth, Crayerstraat 6, 1000 Brussels, Belgium. [email protected]
&
Lieven Annemans Health Economist, Ghent University, De Pintelaan 185, 9000 Gent, Belgium. [email protected]; Senior Consultant, HEDM-IMSHealth, Crayerstraat 6, 1000 Brussels, Belgium
Pages 1931-1943 | Published online: 04 Oct 2006

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Carlos Rubio-Terrés & Santiago Grau. (2010) Pharmacoeconomics of voriconazole. Expert Opinion on Pharmacotherapy 11:6, pages 877-887.
Read now

Articles from other publishers (4)

Daoud Al‐Badriyeh, Danny Liew, Kay Stewart & David C. M. Kong. (2011) Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia. Mycoses 55:3, pages 244-256.
Crossref
Petros Pechlivanoglou, Robin De Vries, Simon M.G.J. Daenen & Maarten J. Postma. (2011) Cost Benefit and Cost Effectiveness of Antifungal Prophylaxis in Immunocompromised Patients Treated for Haematological Malignancies. PharmacoEconomics 29:9, pages 737-751.
Crossref
D. Al-Badriyeh, D. Liew, K. Stewart & D. C. M. Kong. (2009) Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia. Journal of Antimicrobial Chemotherapy 63:6, pages 1276-1285.
Crossref
D. Al-Badriyeh, D. Liew, K. Stewart & D. C. M. Kong. (2008) Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia. Journal of Antimicrobial Chemotherapy 63:1, pages 197-208.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.